title: Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development.
authors.affiliation: Department of Dermatology, Toulouse University, Larrey Hospital, 24 Chemin de Pouvourville, 31059, Toulouse Cedex 9, France.
authors.forename: N
authors.initials: N
authors.lastname: Kirsten
authors.affiliation: Department of Dermatology, Toulouse University, Larrey Hospital, 24 Chemin de Pouvourville, 31059, Toulouse Cedex 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Bulai Livideanu
authors.affiliation: Marseille University and La Timone Hospital, Marseille, France.
authors.forename: M A
authors.initials: MA
authors.lastname: Richard
authors.affiliation: Department of Dermatology, Toulouse University, Larrey Hospital, 24 Chemin de Pouvourville, 31059, Toulouse Cedex 9, France.
authors.forename: M P
authors.initials: MP
authors.lastname: Konstantinou
authors.affiliation: Nice University and L'Archet -2 Hospital, Nice, France.
authors.forename: A
authors.initials: A
authors.lastname: Khemis
authors.affiliation: Department of Dermatology, Toulouse University, Larrey Hospital, 24 Chemin de Pouvourville, 31059, Toulouse Cedex 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Balluteaud
authors.affiliation: Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Goujon
authors.affiliation: Bordeaux University and Saint André Hospital, Bordeaux, France.
authors.forename: M
authors.initials: M
authors.lastname: Beylot-Barry
authors.affiliation: Department of Dermatology, Toulouse University, Larrey Hospital, 24 Chemin de Pouvourville, 31059, Toulouse Cedex 9, France. paul.c@chu-toulouse.fr.
authors.forename: C
authors.initials: C
authors.lastname: Paul
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001685:Biological Factors / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D055808:Drug Discovery; D015507:Drugs, Investigational / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D011565:Psoriasis / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D001685:Biological Factors; D003879:Dermatologic Agents; D015507:Drugs, Investigational